Clinicopathologic analysis of extracapsular extension in prostate cancer: Should the clinical target volume be expanded posterolaterally to account for microscopic extension?-Reference-Cited by-同舟云学术

Clinicopathologic analysis of extracapsular extension in prostate cancer: Should the clinical target volume be expanded posterolaterally to account for microscopic extension?

Published:2006-07 Issue:4 Volume:65 Page:999-1007
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Chao K. Kenneth,Goldstein Neal S.,Yan Di,Vargas Carlos E.,Ghilezan Michel I.,Korman Howard J.,Kernen Kenneth M.,Hollander Jay B.,Gonzalez Jose A.,Martinez Alvaro A.,Vicini Frank A.,Kestin Larry L.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference46 articles.

1. The effect of dose on local control of prostate cancer;Hanks;Int J Radiat Oncol Biol Phys,1988

2. Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformal radiotherapy;Hanks;Cancer J Sci Am,1999

3. Dose selection for prostate cancer patients based on dose comparison and dose response studies;Hanks;Int J Radiat Oncol Biol Phys,2000

4. Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer;Pollack;J Clin Oncol,2000

5. External beam radiotherapy dose response characteristics of 1127 men with prostate cancer treated in the PSA era;Pollack;Int J Radiat Oncol Biol Phys,2000

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Target Volume Optimization for Localized Prostate Cancer;Practical Radiation Oncology;2024-07

2. Prostate Cancer;Target Volume Definition in Radiation Oncology;2023

3. Propensity score-matched analysis comparing dose-escalated intensity-modulated radiation therapy versus external beam radiation therapy plus high-dose-rate brachytherapy for localized prostate cancer;Strahlentherapie und Onkologie;2022-05-12

4. MRI-defined treatment margins, urinary toxicity, and PSA response in LDR prostate brachytherapy;Brachytherapy;2022-03

5. Probabilistic target definition and planning in patients with prostate cancer;Physics in Medicine & Biology;2021-10-28